PH30055A - Hemoregulatory peptides - Google Patents

Hemoregulatory peptides

Info

Publication number
PH30055A
PH30055A PH40815A PH40815A PH30055A PH 30055 A PH30055 A PH 30055A PH 40815 A PH40815 A PH 40815A PH 40815 A PH40815 A PH 40815A PH 30055 A PH30055 A PH 30055A
Authority
PH
Philippines
Prior art keywords
hemoregulatory
peptides
hemoregulatory peptides
compounds
chem
Prior art date
Application number
PH40815A
Other languages
English (en)
Inventor
Pradip Kumar Bhatnagar
William Francis Huffman
James Edward Talmadge
Original Assignee
Smithkline Beecham Coporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Coporation filed Critical Smithkline Beecham Coporation
Publication of PH30055A publication Critical patent/PH30055A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH40815A 1989-07-14 1990-07-10 Hemoregulatory peptides PH30055A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38057889A 1989-07-14 1989-07-14

Publications (1)

Publication Number Publication Date
PH30055A true PH30055A (en) 1996-11-08

Family

ID=23501712

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40815A PH30055A (en) 1989-07-14 1990-07-10 Hemoregulatory peptides

Country Status (25)

Country Link
EP (1) EP0408371B1 (xx)
JP (1) JP2638666B2 (xx)
KR (1) KR910002899A (xx)
CN (1) CN1034663C (xx)
AT (1) ATE112289T1 (xx)
AU (1) AU638468B2 (xx)
CA (1) CA2020838C (xx)
DE (1) DE69012901T2 (xx)
DK (1) DK0408371T3 (xx)
ES (1) ES2064642T3 (xx)
FI (1) FI94354C (xx)
HK (1) HK1004554A1 (xx)
HU (1) HU206889B (xx)
IE (1) IE65533B1 (xx)
IL (1) IL95012A (xx)
MA (1) MA21902A1 (xx)
MX (1) MX21581A (xx)
MY (1) MY106352A (xx)
NO (1) NO177713C (xx)
NZ (1) NZ234501A (xx)
PH (1) PH30055A (xx)
PL (2) PL166004B1 (xx)
PT (1) PT94702B (xx)
ZA (1) ZA905505B (xx)
ZW (1) ZW11290A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW222280B (xx) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
CN1086221A (zh) * 1992-06-02 1994-05-04 哈夫恩伦·尼卡姆德公司 肽化合物
GB9211668D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
ES2052447B1 (es) * 1992-12-14 1995-01-16 Smithkline Beecham Corp Peptidos hemorreguladores.
AU6834194A (en) * 1993-05-14 1994-12-12 Mallinckrodt Medical, Inc. Ligand precursors for incorporation into peptides
WO1994029341A1 (en) * 1993-06-08 1994-12-22 Smithkline Beecham Corporation Methods of enhancing bioactivity of chemokines
GB9314200D0 (en) * 1993-07-09 1993-08-18 Hafslund Nycomed As Peptide compounds
DE69420044T2 (de) * 1993-10-29 2000-03-23 Smithkline Beecham Corp., King Of Prussia Blutregulierende peptide
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
NZ331327A (en) * 1996-02-13 2000-01-28 Akzo Nobel Nv Serine protease inhibitors having an acylguanidine side chain
IL120310A (en) * 1996-03-01 2002-02-10 Akzo Nobel Nv Serine protease inhibitors and pharmaceuticals containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47421B1 (en) * 1977-06-08 1984-03-07 Merck & Co Inc Somatostatin analogs,process for their preparation and pharmaceutical compositions containing them
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
PL166004B1 (pl) 1995-03-31
PT94702A (pt) 1991-03-20
ES2064642T3 (es) 1995-02-01
CA2020838C (en) 2000-05-02
MA21902A1 (fr) 1991-04-01
FI94354B (fi) 1995-05-15
JP2638666B2 (ja) 1997-08-06
JPH0356498A (ja) 1991-03-12
PL286043A1 (en) 1991-03-25
EP0408371A1 (en) 1991-01-16
DE69012901T2 (de) 1995-02-16
EP0408371B1 (en) 1994-09-28
IE902547A1 (en) 1991-02-27
CN1054773A (zh) 1991-09-25
FI903571A0 (fi) 1990-07-13
ZW11290A1 (en) 1990-10-31
PL165133B1 (pl) 1994-11-30
ZA905505B (en) 1991-04-24
HU904201D0 (en) 1990-12-28
ATE112289T1 (de) 1994-10-15
AU638468B2 (en) 1993-07-01
CA2020838A1 (en) 1991-01-15
MY106352A (en) 1995-05-30
IL95012A (en) 1995-03-15
MX21581A (es) 1994-01-31
AU5901490A (en) 1991-01-17
PT94702B (pt) 1997-04-30
HU206889B (en) 1993-01-28
NO177713C (no) 1995-11-08
HUT55034A (en) 1991-04-29
HK1004554A1 (en) 1998-11-27
IE65533B1 (en) 1995-11-01
IL95012A0 (en) 1991-06-10
DE69012901D1 (de) 1994-11-03
KR910002899A (ko) 1991-02-26
NO177713B (no) 1995-07-31
NO903148D0 (no) 1990-07-13
DK0408371T3 (da) 1996-12-16
NO903148L (no) 1991-01-15
FI94354C (fi) 1995-08-25
CN1034663C (zh) 1997-04-23
NZ234501A (en) 1991-08-27

Similar Documents

Publication Publication Date Title
IL133409A0 (en) Retroviral protease inhibiting compounds
IL96790A0 (en) A-nor-steroid-3-carboxylic acid derivatives
MY111201A (en) New imidazopyridines
IL106673A (en) 7-(substituted)-9- £(substituted glycyl) amido|-6- demethyl-6- deoxytetracyclines
IL106676A0 (en) Novel 7-(substituted)-8-(substituted-9-(substituted glycyl)amido)-6-demethyl-6-deoxytetracyclines
ZA905505B (en) Hemoregulatory peptides
IT1191807B (it) Mescole-madri per l'opacizzazione di poliammidi
ZA883444B (xx)
ZA883443B (en) Cyclic anticoagulant peptides
EP0621788A4 (en) Hemoregulatory peptides.
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
BG99062A (en) POLYMORPH "A" OF N-t-BUTYL-ANDROST-3,5-DIENE-17 -CARBOXAMIDE-3-CARBOXYLIC ACID